A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)

Por O'Reilly, Eileen M., Niedzwiecki, Donna, Hall, Margaret, Hollis, Donna, Bekaii-Saab, Tanios, Pluard, Timothy, Douglas, Kathe, Abou-Alfa, Ghassan K., Kindler, Hedy L., Schilsky, Richard L., Goldberg, Richard M.
Publicado em 2010

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

Por Enzinger, Peter C., Burtness, Barbara Ann, Niedzwiecki, Donna, Ye, Xing, Douglas, Kathe, Ilson, David H., Villaflor, Victoria Meucci, Cohen, Steven J., Mayer, Robert J., Venook, Alan, Benson, Al Bowen, Goldberg, Richard M.
Publicado no J Clin Oncol (2016)